Oxidative stress plays an important role in zoledronic acid-induced autophagy

Physiological Research

Volumn 63, Issue , 2014, Pages S601-S612

  Khandelwal, V K M ^a,b,e   Mitrofan, L M ^c   Hyttinen, J M T ^a   Chaudhari, K R ^a   Buccione, R ^b   Kaarniranta, K ^a,d   Ravingerova T ^e   Monkkonen J ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b Department of Translational Pharmacology Consorzio Mario Negri Sud ^*  (Italy)

^c INSERM   (France)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

^e INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Dendra2; FOH; GGOH; LC3B; Prenylation

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; IMIDAZOLE DERIVATIVE; MEVALONIC ACID; ZOLEDRONIC ACID;

AUTOPHAGY; BREAST NEOPLASMS; DRUG EFFECTS; HUMAN; MCF 7 CELL LINE; METABOLISM; OXIDATIVE STRESS;

AUTOPHAGY; BONE DENSITY CONSERVATION AGENTS; BREAST NEOPLASMS; DIPHOSPHONATES; HUMANS; IMIDAZOLES; MCF-7 CELLS; MEVALONIC ACID; OXIDATIVE STRESS;

EID: 84924956553     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. BAGAN J, SAEZ GT, TORMOS MC, GAVALDA-ESTEVE C, BAGAN L, LEOPOLDO-RODADO M, CALVO J, CAMPS C: Oxidative stress in bisphosphonate-related osteonecrosis of the jaws. J Oral Pathol Med 43: 371- 377, 2014.
2. BRUBACHER JL, BOLS NC: Chemically de-acetylated 2',7'-dichlorodihydrofluorescein diacetate as a probe of respiratory burst activity in mononuclear phagocytes. J Immunol Methods 251: 81-91, 2001.
3. CHAUDHARI KR, KUMAR A, KHANDELWAL VKM, MISHRA AK, MONKKONEN J, MURTHY RSR: Targeting efficiency and biodistribution of zoledronate conjugated docetaxel loaded pegylated PBCA nanoparticles for bone metastasis. Adv Funct Mater 22: 4101-4114, 2012a.
4. CHAUDHARI KR, KUMAR A, KHANDELWAL VKM, UKAWALA M, MANJAPPA AS, MISHRA AK, MONKKONEN J, RAMACHANDRA MURTHY RS: Bone metastasis targeting: a novel approach to reach bone using zoledronate anchored PLGA nanoparticle as carrier system loaded with docetaxel. J Control Release 158: 470-478, 2012b.
5. CHEN Y, MCMILLAN-WARD E, KONG J, ISRAELS SJ, GIBSON SB: Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells. Cell Death Differ 15: 171-182, 2008.
6. CLEZARDIN P: Bisphosphonates' antitumor activity: an unravelled side of a multifaceted drug class. Bone 48: 71-79, 2011.
7. COSSARIZZA A, FERRARESI R, TROIANO L, ROAT E, GIBELLINI L, BERTONCELLI L, NASI M, PINTI M: Simultaneous analysis of reactive oxygen species and reduced glutathione content in living cells by polychromatic flow cytometry. Nat Protocols 4: 1790-1797, 2009.
8. COXON FP, HELFRICH MH, VAN'T HOF R, SEBTI S, RALSTON SH, HAMILTON A, ROGERS MJ: Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298. J Bone Miner Res 15: 1467-1476, 2000.
9. DUNFORD JE, THOMPSON K, COXON FP, LUCKMAN SP, HAHN FM, POULTER CD, EBETINO FH, ROGERS MJ: Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. Pharmacol Exp Ther 296: 235-242, 2001.
10. ESKELINEN EL: Doctor Jekyll and Mister Hyde: autophagy can promote both cell survival and cell death. Cell Death Differ 12 (Suppl 2): 1468-1472, 2005.
11. GOFFINET M, THOULOUZAN M, PRADINES A, LAJOIE-MAZENC I, WEINBAUM C, FAYE JC, SERONIEVIVIEN S: Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells. BMC Cancer 6: 60, 2006.
12. GREEN JR: Antitumor effects of bisphosphonates. Cancer 97 (3 Suppl): 840-847, 2003.
13. GREEN JR, MULLER K, JAEGGI KA: Preclinical pharmacology of CGP 42'446, a new, potent, heterocyclic bisphosphonate compound. J Bone Miner Res 9: 745-751, 1994.
14. GUO RT, CAO R, LIANG PH, KO TP, CHANG TH, HUDOCK MP, JENG WY, CHEN CKM, ZHANG Y, SONG Y, KUO CJ, YIN F, OLDFIELD E, WANG AHJ: Bisphosphonates target multiple sites in both cis- and transprenyltransferases. Proc Natl Acad Sci USA 104: 10022-10027, 2007.
15. GURSKAYA NG, VERKHUSHA VV, SHCHEGLOV AS, STAROVEROV DB, CHEPURNYKH TV, FRADKOV AF, LUKYANOV S, LUKYANOV KA: Engineering of a monomeric green-to-red photoactivatable fluorescent protein induced by blue light. Nat Biotech 24: 461-465, 2006.
16. HE C, KLIONSKY DJ: Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 43: 67-93, 2009.
17. HWANG J, LEE S, LEE JT, KWON TK, KIM DR, KIM H, PARK HC, SUK K: Gangliosides induce autophagic cell death in astrocytes. Br J Pharmacol 159: 586-603, 2010.
18. INOUE H, NOJIMA H, OKAYAMA H: High efficiency transformation of Escherichia coli with plasmids. Gene 96: 23-28, 1990.
19. JAGDEV SP, COLEMAN RE, SHIPMAN CM, ROSTAMI-H A, CROUCHER PI: The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel. Br J Cancer 84: 1126- 1134, 2001.
20. JU JS, WEIHL CC: Inclusion body myopathy, Paget's disease of the bone and fronto-temporal dementia: a disorder of autophagy. Hum Mol Genet 19: R38-R45, 2010.
21. KLIONSKY DJ, ABELIOVICH H, AGOSTINIS P, AGRAWAL DK, ALIEV G, ASKEW DS, BABA M, BAEHRECKE EH, BAHR BA, BALLABIO A: Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4: 151-175, 2008.
22. KOçER G, NAZIROGLU M, çELIK ö, öNAL L, öZçELIK D, KOçER M, SöNMEZ TT: Basic fibroblast growth factor attenuates bisphosphonate-induced oxidative injury but decreases zinc and copper levels in oral epithelium of rat. Biol Trace Elem Res 153: 251-256, 2013.
23. LEVINE B, KLIONSKY DJ: Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 6: 463-477, 2004.
24. LIN JF, LIN YC, LIN YH, TSAI TF, CHOU KY, CHEN HE, HWANG TIS: Zoledronic acid induces autophagic cell death in human prostate cancer cells. J Urol 185: 1490-1496, 2011.
25. MITROFAN LM, PELKONEN J, MöNKKöNEN J: The level of ATP analog and isopentenyl pyrophosphate correlates with zoledronic acid-induced apoptosis in cancer cells in vitro. Bone 45: 1153-1160, 2009.
26. MITROFAN LM, CASTELLS FB, PELKONEN J, MöNKKöNEN J: Lysosomal-mitochondrial axis in zoledronic acid-induced apoptosis in human follicular lymphoma cells. J Biol Chem 285: 1967-1979, 2010.
27. MIZUSHIMA N, YOSHIMORI T: How to interpret LC3 immunoblotting. Autophagy 3: 542-545, 2007.
28. MöNKKöNEN H, AURIOLA S, LEHENKARI P, KELLINSALMI M, HASSINEN IE, VEPSäLäINEN J, MöNKKöNEN J: A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates. Br J Pharmacol 147: 437-445, 2006.
29. MöNKKöNEN H, OTTEWELL PD, KUOKKANEN J, MöNKKöNEN J, AURIOLA S, HOLEN I: Zoledronic acidinduced IPP/ApppI production in vivo. Life Sci 81: 1066-1070, 2007.
30. MöNKKöNEN H, KUOKKANEN J, HOLEN I, EVANS A, LEFLEY DV, JAUHIAINEN M, AURIOLA S, MöNKKöNEN J: Bisphosphonate-induced ATP analog formation and its effect on inhibition of cancer cell growth. Anticancer Drugs 19: 391-399, 2008.
31. MORICEAU G, ORY B, MITROFAN L, RIGANTI C, BLANCHARD F, BRION R, CHARRIER C, BATTAGLIA S, PILET P, DENIS MG, SHULTZ LD, MöNKKöNEN J, RéDINI F, HEYMANN D: Zoledronic acid potentiates mTOR inhibition and abolishes the resistance of osteosarcoma cells to RAD001 (everolimus): pivotal role of the prenylation process. Cancer Res 70: 10329-10339, 2010.
32. OTTEWELL PD, WOODWARD JK, LEFLEY DV, EVANS CA, COLEMAN RE, HOLEN I: Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone. Mol Cancer Ther 8: 2821-2832, 2009.
33. PAGLIN S, HOLLISTER T, DELOHERY T, HACKETT N, MCMAHILL M, SPHICAS E, DOMINGO D, YAHALOM J: A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res 61: 439-444, 2001.
34. PAN J, SONG E, CHENG C, LEE MH, YEUNG SC: Farnesyltransferase inhibitors-induced autophagy: Alternative mechanisms? Autophagy 5: 129-131, 2009.
35. RäIKKöNEN J, CROCKETT JC, ROGERS MJ, MöNKKöNEN H, AURIOLA S, MöNKKöNEN J: Zoledronic acid induces formation of a pro-apoptotic ATP analogue and isopentenyl pyrophosphate in osteoclasts in vivo and in MCF-7 cells in vitro. Br J Pharmacol 157: 427-435, 2009.
36. ROGERS MJ, CROCKETT JC, COXON FP, MöNKKöNEN J: Biochemical and molecular mechanisms of action of bisphosphonates. Bone 49: 34-41, 2011.
37. SAMBROOK J, FRITSCH EF, MANIATIS T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, New York, 1989, pp 25-28.
38. SCHERZ-SHOUVAL R, SHVETS E, FASS E, SHORER H, GIL L, ELAZAR Z: Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J 26: 1749-1760, 2007.
39. SHVETS E, FASS E, ELAZAR Z: Utilizing flow cytometry to monitor autophagy in living mammalian cells. Autophagy 4: 621-628, 2008.
40. SONNEMANN J, BUMBUL B, BECK JF: Synergistic activity of the histone deacetylase inhibitor suberoylanilide hydroxamic acid and the bisphosphonate zoledronic acid against prostate cancer cells in vitro. Mol Cancer Ther 6: 2976-2984, 2007.
41. TAKEUCHI H, KONDO Y, FUJIWARA K, KANZAWA T, AOKI H, MILLS GB, KONDO S: Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3- kinase/protein kinase B inhibitors. Cancer Res 65: 3336-3346, 2005.
42. THOMPSON K, ROGERS M: The molecular mechanisms of action of bisphosphonates. Clin Rev Bone Miner Metab 5: 130-144, 2007.
43. VESA J, SU H, WATTS GD, KRAUSE S, WALTER MC, MARTIN B, SMITH C, WALLACE DC, KIMONIS VE: Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts. Neuromuscul Disord 19: 766-772, 2009.
44. WASKO BM, DUDAKOVIC A, HOHL RJ: Bisphosphonates induce autophagy by depleting geranylgeranyl diphosphate. Pharmacol Exp Ther 337: 540-546, 2011.
45. YAMAMOTO A, TAGAWA Y, YOSHIMORI T, MORIYAMA Y, MASAKI R, TASHIRO Y: Bafilomycin A 1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct Funct 23: 33-42, 1998.
46. ZHUANG W, QIN Z, LIANG Z: The role of autophagy in sensitizing malignant glioma cells to radiation therapy. Acta Biochim Biophys Sin 41: 341-351, 2009.